Category: CytoReason

Israeli biopharmaceutical decision-making company citorisonTechnologies, which develops AI-powered computational disease models for predictive insights, today announced the completion of an $80 million funding round from OurCrowd, Nvidia, Pfizer, and Thermo Fisher Scientific. Cytorison says it will use the new funds to expand the application of its models in additional indications,…

Israeli biopharmaceutical decision-making company citorisonTechnologies, which develops AI-powered computational disease models for predictive insights, today announced the completion of an $80 million funding round from OurCrowd, Nvidia, Pfizer, and Thermo Fisher Scientific. Cytorison says it will use the new funds to expand the application of its models in additional indications,…